Agilent has acquired the Kalabie Electronic Laboratory Notebook (ELN) from Klee Group to expand its informatics offerings and provide its first ELN offering.
"With the addition of Kalabie, Agilent can provide customers with a complete software solution and a single-vendor approach to their laboratory management needs," said Bruce von Herrmann, vice president and general manager for Agilent's Software and Informatics Division.
"ELNs simplify knowledge and data integration. The combined capabilities of Kalabie ELN, OpenLAB and GeneSpring provide unique capabilities that enhance productivity."
Biotage has decided to leverage its product offerings into the Molecular Imaging arena following a successful start to its molecular imaging collaboration with McMaster University earlier in the year.
Biotage's instruments will be used to synthesise the short half life radio-labelled compounds that are used in techniques such as SPECT (single photon computed tomography) and PET (positron emission tomography).
"Imaging is an intriguing challenge for Biotage. Biotage is uniquely positioned to exploit these market segments. We see very interesting collaboration possibilities in this field that will help to drive further development of Biotage's business." says Kelvin Hammond, vice president of Business Development at Biotage.
Chenomx and GeneGo have teamed up to provide data integration between their software products to aid in metabolomics research.
Chenomx provides software and compound libraries for NMR-based metabolomics studies, while GeneGo provides data analysis software for mass spectrometry (MS) -based systems biology and pathway analysis.
"Our customers will now be able to combine Chenomx NMR Suite's powerful metabolite identification and quantification capabilities with GeneGo's pathway analysis tools [and] allows our customers to integrate genomic and proteomic data sources with their Chenomx metabolomics data," said Jack Newton, director of Product Development for Chenomx.
Oxford Gene Technology (OGT) has granted Aushon BioSystems access to its "Southern array patents" that cover the manufacture and marketing of oligonucleotide microarrays.
The agreement will remain valid for the lifetime of the patents, however no financial terms were disclosed.
"This agreement will enable Aushon to provide high quality, flexible and affordable oligonucleotide microarray products to our customers in life science research, drug discovery/development, and clinical diagnostics," said John Austin, president of Aushon BioSystems.
Phenomenex has announced an agreement with Beckman Coulter (BC) that grants them exclusive distribution rights to BC's ProteomeLab IgY enrichment products in the US, Canada and countries in the EU.
"Protein partitioning is a critical part of any biomarker discovery program and we view the ProteomeLab IgY products as the best available," said Michael McGinley, Phenomenex Biochromatography Product Manager.
"These columns fit well with our portfolio of complete proteomics solutions for the separation of proteins and peptides."
Sigma-Aldrich has entered into a licensing agreement with Epigentek Group to develop and commercialise technologies for epigenetics research.
"Sigma-Aldrich has identified Epigenetics as a growing area of interest and research for heritable diseases such as cancer, Alzheimer's and many others," said Keith Jolliff, director of Genomics and Functional Genomics at Sigma-Aldrich.
"We see the licensing with Epigentek as the right fit to our ongoing commitment to provide best-in-class solutions to the research community and an excellent entry point to supporting Epigenetics research."
This entry will begin with the launch of the Imprint DNA modification kit later this month and will be followed by kits for global methylation quantitation and chromatin immunoprecipitation.
